Related references
Note: Only part of the references are listed.SUSTAINED INTRA-ARTICULAR DELIVERY OF IL-1RA FROM A THERMALLY-RESPONSIVE ELASTIN-LIKE POLYPEPTIDE AS A THERAPY FOR POST-TRAUMATIC ARTHRITIS
K. A. Kimmerling et al.
EUROPEAN CELLS & MATERIALS (2015)
Assessment of release kinetics, stability and polymer interaction of poloxamer 407-based thermosensitive gel of interleukin-1 receptor antagonist
Muhammad Sajid Hamid Akash et al.
PHARMACEUTICAL DEVELOPMENT AND TECHNOLOGY (2014)
Nanoengineered Particles for Enhanced Intra-Articular Retention and Delivery of Proteins
Ankur Singh et al.
ADVANCED HEALTHCARE MATERIALS (2014)
The effect of anakinra, an IL1 receptor antagonist, in patients with sporadic inclusion body myositis (sIBM): A small pilot study
Michalis L. Kosmidis et al.
JOURNAL OF THE NEUROLOGICAL SCIENCES (2013)
IL-1Ra and its Delivery Strategies: Inserting the Association in Perspective
Muhammad Sajid Hamid Akash et al.
PHARMACEUTICAL RESEARCH (2013)
Self-assembling nanoparticles for intra-articular delivery of anti-inflammatory proteins
Rachel E. Whitmire et al.
BIOMATERIALS (2012)
被撤回的出版物: Controlled-release and preserved bioactivity of proteins from (self-assembled) core-shell double-walled microspheres (Retracted article. See vol. 13, pg. 2275, 2018)
Weien Yuan et al.
INTERNATIONAL JOURNAL OF NANOMEDICINE (2012)
Pro-oxidant and antioxidant effects of N-acetylcysteine regulate doxorubicin-induced NF-kappa B activity in leukemic cells
Nnenna Adimora Finn et al.
MOLECULAR BIOSYSTEMS (2012)
Effects of intraarticular IL1-Ra for acute anterior cruciate ligament knee injury: a randomized controlled pilot trial (NCT00332254)
V. B. Kraus et al.
OSTEOARTHRITIS AND CARTILAGE (2012)
Sustained Delivery of IL-1Ra from Pluronic F127-Based Thermosensitive Gel Prolongs its Therapeutic Potentials
Muhammad Sajid Hamid Akash et al.
PHARMACEUTICAL RESEARCH (2012)
Desperately looking for the right target in osteoarthritis: the anti-IL-1 strategy
Xavier Chevalier et al.
ARTHRITIS RESEARCH & THERAPY (2011)
Binding Affinity and Kinetic Analysis of Targeted Small Molecule-Modified Nanoparticles
Carlos Tassa et al.
BIOCONJUGATE CHEMISTRY (2010)
One in four people may develop symptomatic hip osteoarthritis in his or her lifetime
L. B. Murphy et al.
OSTEOARTHRITIS AND CARTILAGE (2010)
Lifetime risk of symptomatic knee osteoarthritis
Louise Murphy et al.
ARTHRITIS & RHEUMATISM-ARTHRITIS CARE & RESEARCH (2008)
How to achieve sustained and complete protein release from PLGA-based microparticles?
A. Giteau et al.
INTERNATIONAL JOURNAL OF PHARMACEUTICS (2008)
Estimates of the prevalence of arthritis and other rheumatic conditions in the United States
Reva C. Lawrence et al.
ARTHRITIS AND RHEUMATISM (2008)
Sustained delivery of IL-1Ra from biodegradable microspheres reduces the number of murine B16 melanoma lung metastases
Galia Lavi et al.
JOURNAL OF CONTROLLED RELEASE (2007)
Investigation on PEGylation strategy of recombinant human interleukin-1 receptor antagonist
Pengzhan Yu et al.
BIOORGANIC & MEDICINAL CHEMISTRY (2007)
The economic burden associated with osteoarthritis, rheumatoid arthritis, and hypertension: a comparative study
A Maetzel et al.
ANNALS OF THE RHEUMATIC DISEASES (2004)
The impact of osteoarthritis -: Implications for research
JA Buckwalter et al.
CLINICAL ORTHOPAEDICS AND RELATED RESEARCH (2004)
Pressure and shear differentially alter human articular chondrocyte metabolism - A review
RL Smith et al.
CLINICAL ORTHOPAEDICS AND RELATED RESEARCH (2004)
Effectiveness of the soluble form of the interleukin-1 receptor accessory protein as an inhibitor of. interleukin-1 in collagen-induced arthritis
RL Smeets et al.
ARTHRITIS AND RHEUMATISM (2003)
Effect of blending calcium compounds on hydrolytic degradation of poly(DL-lactic acid-co-glycolic acid)
M Ara et al.
BIOMATERIALS (2002)
Gene therapy for rheumatoid arthritis - Lessons from animal models, including studies on interleukin-4, interleukin-10, and interleukin-1 receptor antagonist as potential disease modulators
FAJ van de Loo et al.
RHEUMATIC DISEASE CLINICS OF NORTH AMERICA (2002)
Treatment of experimental equine osteoarthritis by in vivo delivery of the equine interleukin-1 receptor antagonist gene
DD Frisbie et al.
GENE THERAPY (2002)
Tumour necrosis factor-alpha, interleukin-1 beta and interleukin-8 induce persistent mechanical nociceptor hypersensitivity
D Sachs et al.
PAIN (2002)
Share Paper
